Planejamento do meio físico a partir de uma abordagem da técnica de capacidade de uso da terra na sub-bacia dso Rio das Pedras - Itatinga - SP

The study aimed mapping of the land use capacity classes for the Rio das Pedras watershed, Itatinga-SP in order to provide another mechanism of environmental planning for the studied area. It was used 1:10,000 topographic letters for the slope map generation which was overlaid with the studied area soil map. It was applied the judgment table criteria method, for generation of land use capacity map of the studied area. It were identified the following results: First, class III with constraints in relation of low fertility and restrictions about erosion risks on high slope areas. Second, class VI with the same characteristics of class III however with the presence of an aggravating factor of sand texture in all horizons, resulting in high risks of erosion events, especially in high slopes areas, and contamination by pollutants due the high soil permeability. Conclusions: It was verified that the more critical regions for land use capacity classes were VIs and mainly VIes class. The last one has more high relief areas and the presence of Neossolo Quartzarenico soil, with a big erosion propensity. The land use capacity map allow making different decisions for each region of the watershed respecting their individual characteristics.

Molecular analysis of the PROP1 and HESX1 genes in patients with septo-optic dysplasia and/or pituitary hormone deficiency

OBJETIVO: O presente estudo teve como objetivo avaliar os genes PROP1 e HESX1 em um grupo de pacientes com displasia septo-óptica (DSO) e deficiência hormonal hipofisária (combinada - DHHC; ou deficiência isolada de GH - DGH). Onze pacientes com apresentação clínica e bioquímica consistente com DHHC, DGH ou DSO foram avaliados. SUBJECTS and METHODS: em todos os pacientes, o gene HESX1 foi analisado pelo sequenciamento direto e, nos casos de DHHC, o gene PROP1 foi também sequenciado. RESULTADOS: Um polimorfismo no gene HESX1 (1772 A > G; N125S) foi identificado em um paciente com DSO. Foram encontrados três pacientes portadores da variação alélica 27 T > C; A9A e 59 A > G; N20S no éxon 1 do gene PROP1. Mutações no gene PROP1 e HESX1 não foram identificadas nesses pacientes com DGH, DHHC e DSO esporádicos. CONCLUSÃO: Alterações genéticas em um ou diversos outros genes ou mecanismos não genéticos devem estar implicados nesse processo patogênico.

Estudo clínico e molecular de pacientes com displasia septo-ótica ou deficiência hormonal hipofisária (gene HESX1 e PROP1)

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Plataforma de simulação computacional paralela com base nos conceitos de relógios lógicos e tempo virtual

Pós-graduação em Ciência da Computação - IBILCE

Localização automática de pontos de controle em imagens aéreas baseada em cenas terrestres verticais

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Analysis of generalized interictal discharges using quantitative EEG

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Molecular analysis of the PROP1 and HESX1 genes in patients with septo-optic dysplasia and/ or pituitary hormone deficiency

Objective: The present study aimed at evaluating the PROP1 and HESX1 genes in a group of patients with septo-optic dysplasia (SOD) and pituitary hormone deficiency (combined – CPHD; isolated GH deficiency – GHD). Eleven patients with a clinical and biochemical presentation consistent with CPHD, GHD or SOD were evaluated. Subjects and methods: In all patients, the HESX1 gene was analyzed by direct sequence analysis and in cases of CPHD the PROP1 gene was also sequenced. Results: A polymorphism (1772 A > G; N125S) was identified in a patient with SOD. We found three patients carrying the allelic variants 27 T > C; A9A and 59 A > G; N20S in exon 1 of the PROP1 gene. Mutations in the PROP1 and HESX1 genes were not identified in these patients with sporadic GHD, CPHD and SOD. Conclusion: Genetic alterations in one or several other genes, or non-genetic mechanisms, must be implicated in the pathogenic process.